Asset Allocation

As of December 31, 2025.
Type % Net
Cash 1.18%
Stock 57.62%
Bond 32.39%
Convertible 0.00%
Preferred 1.70%
Other 7.11%
View Asset Allocation
Start Trial

Market Capitalization

Large --
Mid --
Small --
No Data Available
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 91.06%    % Emerging Markets: 0.29%    % Unidentified Markets: 8.65%

Americas 83.84%
83.76%
Canada 57.17%
United States 26.59%
0.08%
As of December 31, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 5.78%
United Kingdom 3.16%
2.62%
Denmark 0.16%
France 0.62%
Germany 0.75%
Netherlands 0.36%
Switzerland 0.43%
0.00%
0.00%
Greater Asia 1.73%
Japan 0.52%
0.06%
Australia 0.06%
0.99%
Hong Kong 0.23%
Singapore 0.04%
South Korea 0.52%
0.16%
China 0.16%
Unidentified Region 8.65%

Bond Credit Quality Exposure

AAA 14.14%
AA 5.38%
A 7.54%
BBB 21.10%
BB 30.74%
B 10.29%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.17%
Not Available 10.64%
Short Term 0.00%
As of December 31, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
42.94%
Materials
10.24%
Consumer Discretionary
4.41%
Financials
26.78%
Real Estate
1.52%
Sensitive
38.69%
Communication Services
3.89%
Energy
10.65%
Industrials
11.31%
Information Technology
12.84%
Defensive
8.26%
Consumer Staples
2.83%
Health Care
2.93%
Utilities
2.51%
Not Classified
10.11%
Non Classified Equity
0.60%
Not Classified - Non Equity
9.50%
As of December 31, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of December 31, 2025
Type % Net
Government 9.31%
Corporate 70.10%
Securitized 1.12%
Municipal 7.79%
Other 11.68%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
0.95%
Less than 1 Year
0.95%
Intermediate
66.08%
1 to 3 Years
5.53%
3 to 5 Years
20.73%
5 to 10 Years
39.83%
Long Term
28.07%
10 to 20 Years
7.44%
20 to 30 Years
11.36%
Over 30 Years
9.27%
Other
4.90%
As of December 31, 2025
View Bond Maturity Exposure
Start Trial